Influence of IGF-I and cell density on MDR1 expression in the T-lymphoblastoid cell line CCRF-CEM

Hormone Research

Volumn 52, Issue 4, 1999, Pages 192-199

  Schwarze, C P ^a,b   Neu, S ^a   Beck, J ^a   Mavridou, K ^a,b   Ranke, M B ^a,b   Binder, G ^a,b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Growth Research Center   (Germany)

Author keywords

Gene expression; Growth hormone therapy; IGF I; Leukemia; Multidrug resistance

Indexed keywords

GLYCOPROTEIN P; MESSENGER RNA; RHODAMINE 123; SOMATOMEDIN C;

ARTICLE; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOBLAST;

EID: 0033510881     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023460     Document Type: Article

References (41)

1. Stahnke N, Zeisel HJ: Growth hormone therapy and leukemia. Eur J Pediatr 1989;148:591-596.
2. Shalet SM: Leukaemia in children treated with growth hormone. J Pediatr Endocrinol 1993;6: 109-111.
3. Zadik Z, Estrov Z, Karov Y, Hahn T, Barak Y: The effect of growth hormone and IGF-I on clonogenic growth of hematopoetic cells in leukemic patients during active disease and during remission: A preliminary report. J Pediatr Endocrinol 1993;6:79-83.
4. Rinderknecht E, Humbel RE: The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 1978;253:2769-2776.
5. Kelley KW, Arkins S, Li YM, Biragyn A: Growth hormone, insulin-like growth factor I, and immune function; in Müller EE, Cocchi D, Locatelli V (eds): Growth Hormone and Somatomedins during Lifespan. Berlin, Springer, 1993, pp 173-192.
6. Clark R, Strasser J, McCabe S, Robbins K, Jardieu P: Insulin-like growth factor-1 stimulation of lymphopoiesis. J Clin Invest 1993;92:540-548.
7. Kooijman R, Willems M, De Haas CJC, Rijkers GT, Schuurmans ALG, Van Buul-Offers SC, Heijnen CJ, Zegers BJM: Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 1992;131:2244-2250.
8. Merchav S, Tatarsky I, Hochberg Z: Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin-like growth factor I. Br J Haematol 1988;70:267-271.
9. Macaulay VM: Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-320.
10. Herandez-Sanchez C, Lopez-Carranza A, Alarcon C, De La Rosa EJ, De Pablo F: Autocrine/ paracrine role of insulin-related growth factors in neurogenesis: Local expression and effects on cell proliferation and differentiation in retina. Proc Natl Acad Sci USA 1995;92:9834-9838.
11. Geier A, Hemi R, Haimsohn M, Berry R, Malik Z, Karasik A: Epidermal growth factor and insulin-like growth factor-1 protect MDA-231 cells from cell death induced by actinomycin D: The involvement of growth factors in drug resistance. In Vitro Cell Dev Biol 1994;30A: 336-343.
12. Geier A, Beery R, Haimsohn M, Karasik A: Insulin-like growth factor-1 inhibits cell death induced by anticancer drugs in the MCF-7 cells: Involvement of growth factors in drug resistance. Cancer Invest 1995;13:480-486.
13. Bailly JD, Pourquier P, Jaffrezou JP, Duchayne E, Cassar G, Bordier C, Laurent G: Effect of 5637-conditioned medium and recombinant cytokines on P-glycoprotein expression in a human GM-CSF-dependent leukemic myeloid cell line. Leukemia 1995;9:1718-1725.
14. Shapiro DN, Jones BG, Shapiro LH, Dias P, Houghton PJ: Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J Clin Invest 1994;94:1235-1242.
15. Guo YS, Jin GF, Houston CW, Thompson JC, Townsend CM Jr: Insulin-like growth factor-1 promotes multidrug resistance in MCLM colon cancer cells. J Cell Physiol 1998;175:141-148.
16. Rechler MM, Nissley SP: The nature and regulation of the receptors for insulin-like growth factors. Ann Rev Physiol 1985;47:425-442.
17. Lee PDK, Rosenfeld RG, Hintz, RL. Smith SD: Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemie lymphoblasts. J Clin Endocrinol Metab 1986;62:28-35.
18. Baier TG, Ludwig WD, Schönberg D, Hartmann KKP: Characterisation of insulin-like growth factor I receptors of human acute lymphoblastic leukeamia (ALL) cell lines and primary ALL. Eur J Cancer 1992;28A:1105-1110.
19. Nissley SP, Haskell JF, Sasaki N, De Vroede MA, Rechler MM: Insulin-like growth factor receptors. J Cell Sci 1985;3(suppl):39-51.
20. Robinson LJ, Leitner W, Draznin B, Heidenreich K: Evidence that p21ras mediates the neurothrophic effects of insulin and insulin-like growth factor I in chick forebrain neurons. Endocrinology 1994;135:2568-2573.
21. Chin K-V, Ueda K, Pastan I, Gottesman MM: Modulation of activity of the promoter of the human MDR 1 gene by ras and p53. Science 1992;255:459-461
22. Germann UA: P-glycoprotein: A mediator of multidrug resistance in tumour cells. Eur J Cancer 1996;32A:927-944.
23. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG: Overexpression of a transporter gent in a multidrug-resistant human lung cancer cell line. Science 1992;258: 1650-1654.
24. Hochhauser D, Harris AL: The role of topoisomerase IIα and β in drug resitance. Cancer Treat Rev 1993;19:181-194.
25. Marie JP, Zhou DC, Gurbuxani S, Legrand O, Zittoun R: MDR1/P-glycoprotein in haematological neoplasms. Eur J Cancer 1996;32A: 1034-1038.
26. Goldstein LJ: MDR1 gene expression in solid tumours. Eur J Cancer 1996:32A:1039-1050.
27. Hirsch-Ernst KI, Ziemann C, Schmitz-Salue C, Foth H, Kahl GF: Modulation of P-glycoprotein and mdr1b mRNA expression by growth factors in primary rat hepatocyte culture. Biochem Biophys Res Commun 1995;215:179-185.
28. Foley GE, Lazerus H, Farber S, Geren Uzman B. Boone BA, McCarthy RE: Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 1965;18:522-529.
29. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB: Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990;87:7160-7164.
30. Siebert PD, Larrick JW: Competitive PCR. Nature 1992;359:557-558.
31. Ludescher C, Hilbe W, Eisterer W, Preuss E, Huber C, Gotwald M, Hofman J, Thaler J: Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay. J Natl Cancer Inst 1993;85: 1751-1758.
32. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le-Bon T, Kathuria S, Chen E: Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define specificity. EMBO J 1986;5: 2503-2512.
33. Blum WF, Gallaher B, Ranke MB: An IGFBP-blocked IGF-I RIA that measures what it pretends to measure: IGF-I (abstract). Proc 74th Ann Meet Endocrine Soc 1992; p 293.
34. Beck J, Handgretinger R, Dopfer R, Klingebiel T, Niethammer D, Gekeler V: Expression of mdr1, MRP, topoisomerase II α/β, and cyclin A in primary or relapsed states of acute lymphoblastic leukeamias. Br J Haematol 1995;89: 356-363.
35. Burke TW, Vuk-Pavlovic S: Insulin-like growth factor-I is a serum component stimulating growth of human neuroblastoma. In Vitro Cell Dev Biol 1993;29A:391-394.
36. Sinclair J, McClain D, Taetle R: Effects of insulin and insulin-like growth factor I on growth of human leukemia cells in serum-free and protein-free medium. Blood 1988;72:66-72.
37. Licht T, Pastan I, Gottesman M, Hermann F: P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoetic cells. Ann Hematol 1994;69:159-171.
38. Gekeler V, Beck J, Noller A, Wilisch A, Frese G, Neumann M, Handgretinger R, Ehninger G, Probst H, Niethammer D: Drug-induced changes in the expression of MDR-associated genes: Investigations on cultured cell lines and chemotherapeutically treated leukemias. Ann Hematol 1994;69:S19-S24.
39. Zen K, Masuda J, Sasaguri T, Kosaka C, Ogata J: Gene expression of monocyte chemoattractant protein-1 in human monocytes is regulated by cell density through protein tyrosine kinase and protein kinase C. Exp Cell Res 1994;215: 172-179.
40. Lin MF, Garcia-Arenas R: Effect of cell density on androgen regulation of the mRNA level of human prostatic acid phosphatase. Mol Cell Endocrinol 1994;99:R21-R24.
41. Kutoh E, Schwander J, Margot JB: Cell-density-dependent modulation of the rat insulin-like-growth-factor-binding protein 2 and its gene. Eur J Biochem 1995;234:557-562.